August 2023

Ind-Swift Limited - Jawaharpur, Derabassi is the Ace unit of Ind-Swift Limited, was created in the year 2005 with an aim to globalize the Ind-Swift brand for finished dosage forms. We are a 100% Export Oriented Unit dealing in regulated markets having approval like MHRA, TGA & GLC etc.

IPCA LABORATORIES LIMITED is an Indian multinational pharmaceutical company. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules and sells these formulations domestic and global market. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents.

Macleods Pharmaceuticals, fastest growing company was established in 1986. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140 plus countries. Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities.

Post : Officer / Sr. Officer / Technical Associate / Operator

Lincoln Pharmaceuticals Ltd., Ahmedabad based 40 years old, public limited having presence in 75+ countries, 1700+ registered products, own Manufacturing and R&D center and among india’s top 70 pharma company.

For Khatraj Unit

Lupin Limited is one of India's largest manufacturers of bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and herbal resources supported by the discipline of modern medicine.

Granules India - A vertically integrated, high growth pharmaceutical company with 38 glorious years of proven performance and an increasing global presence. We have been revolutionising work culture by promoting policies with this initiative, we look forward to setting a benchmark for the industry to operate in the future.

WALK IN DRIVE FOR QUALITY CONTROL

Post : Executive / Sr. Executive

The National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months. Treatments will include drugs, biologics, medical devices and other therapies. The trials are designed to evaluate multiple treatments simultaneously to identify more swiftly those that are effective.

Merck known as MSD outside of the United States and Canada, announced that the pivotal Phase 3 KEYNOTE-756 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy met one of its dual primary endpoints of pathological complete response (pCR) rate following the neoadjuvant part of the neoadjuvant/adjuvant study regimen in patients with high-risk, early-stage estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) breast cancer.

Glenmark Pharmaceuticals Ltd. is an integrated, research‐led, global pharmaceutical company, with a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.